Wikipedia:Version 1.0 Editorial Team/Pharmacology articles by quality log

July 29, 2025

Renamed

• AM-2-19 renamed to Turletricin.

Reassessed

• 177 Lu-NNS309 (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
• 1cP-MIPLA (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t) Importance rating changed from Unknown-Class to Low-Class. (rev · t)
• 2,3,4,6-Tetramethoxyamphetamine (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t) Importance rating changed from Unknown-Class to Low-Class. (rev · t)
• 2,3,4,6-Tetramethoxyphenethylamine (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t) Importance rating changed from Unknown-Class to Low-Class. (rev · t)
• 2,3,5,6-Tetramethoxyphenethylamine (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t) Importance rating changed from Unknown-Class to Low-Class. (rev · t)
• 2,4,6-Trimethoxyphenethylamine (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t) Importance rating changed from Unknown-Class to Low-Class. (rev · t)
• Cipargamin (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
• Divarasib (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
• Luxdegalutamide (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
• Mosunetuzumab (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
• Obinutuzumab (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
• PNU-22394 (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

Assessed

• 2CBecca (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Category:Androgens (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
• F (psychedelic) (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Fenebrutinib (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Nivegacetor (talk) assessed. Quality assessed as C-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Turletricin (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• Votoplam (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

Removed

• Category:Anabolic–androgenic steroids (talk) removed.

July 28, 2025

Renamed

• ALTO-100 renamed to Amdiglurax.
• NBI-1117568 renamed to Direclidine.
• NNZ-2591 renamed to Ercanetide.
• NV-5138 renamed to Mefluleucine.
• RE-104 renamed to Luvesilocin.
• SP-624 renamed to Forvisirvat.

Reassessed

• 1F-LSD (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
• Personal care products (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)

Assessed

• 2C-T-9 (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• Amdiglurax (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• BK-6-MAPB (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• Bifikafusp alfa/onfekafusp alfa (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)
• Deudimethyltryptamine (talk) assessed. Quality assessed as List-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• Direclidine (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• Ercanetide (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Forvisirvat (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• IPLA (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• L-Iso-LSD (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• L-LSD (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• Luvesilocin (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Lysergic acid diethylamide (disambiguation) (talk) assessed. Quality assessed as List-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• Mefluleucine (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• SPL028 (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• Zervimesine (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)

July 27, 2025

Reassessed

• 2C-B-5-hemiFLY-α6 (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t)

Assessed

• 1F-LSD (talk) assessed. Importance assessed as Unknown-Class. (rev · t)
• 3,4,5-Trimethoxytranylcypromine (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• 4-AcO-MALT (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• DIPLA (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• List of cannabinoids (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• List of entactogens (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• List of hallucinogens (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• MAL-LAD (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)

July 26, 2025

Reassessed

• 2-Oxo-3-hydroxy-LSD (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
• Lovotibeglogene autotemcel (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

Removed

• Category:Pharmaceutical companies established in 1937 (talk) removed.

July 25, 2025

Renamed

• Lewis B. Sheiner renamed to Lewis B. Sheiner.

Reassessed

• 2,5-Dimethoxy-4-isobutylamphetamine (talk) reassessed. Quality rating changed from Start-Class to Stub-Class. (rev · t)
• Seeding trial (talk) reassessed. Quality rating changed from B-Class to C-Class. (rev · t)

Assessed

• Naminidil (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• P-1075 (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)

July 24, 2025

Reassessed

• Addiction (talk) reassessed. Quality rating changed from B-Class to C-Class. (rev · t)
• Masitinib (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

July 23, 2025

Assessed

• NeoGenomics (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Draft:Royal Honey (talk) assessed. Importance assessed as NA-Class. (rev · t)